Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Axsome Therapeutics depression drug AXS-05 meets goal in late-stage trial

      Axsome Therapeutics depression drug AXS-05 meets goal in late-stage trial

      Medical Dialogues Bureau17 Dec 2019 9:10 AM IST
      The trial results of Axsome Therpeutics' oral tablet, AXS-05 takes the company a step closer to acquiring a share of the multi-billion dollar market...
      Glenmark Baddi unit gets GMP certificate from State Institute for Drug Control

      Glenmark Baddi unit gets GMP certificate from State Institute for Drug Control

      Medical Dialogues Bureau16 Dec 2019 3:22 PM IST
      "The European regulator has just issued a certificate of compliance for the facility stating that it complies with the principles and guidelines of...
      Amarin fish-oil drug Vascepa gets USFDA nod for cutting cardiac risks

      Amarin fish-oil drug Vascepa gets USFDA nod for cutting cardiac risks

      Medical Dialogues Bureau16 Dec 2019 11:48 AM IST
      Fish-oil based Vascepa sales brought Amarin just $287 million over 2019's first nine months, but analysts forecast the much-broader approval could...
      Horizon Therapeutics thyroid eye disease drug Teprotumumab gets USFDA panel votes

      Horizon Therapeutics thyroid eye disease drug Teprotumumab gets USFDA panel votes

      Medical Dialogues Bureau16 Dec 2019 10:00 AM IST
      If approved, Horizon Therapeutics Plc's teprotumumab, a type of immunotherapy, is expected to become a standard of care for the vision-threatening...
      Abbott CEO Miles D White to step down in 2020, Robert B Ford to take over

      Abbott CEO Miles D White to step down in 2020, Robert B Ford to take over

      Medical Dialogues Bureau16 Dec 2019 9:30 AM IST
      Robert B Ford will become the 13th CEO of Abbott in its 131-year history, all having been appointed from within the Company, a testament to Abbott's...
      Sackler-owned opioid maker pushes overdose treatment abroad

      Sackler-owned opioid maker pushes overdose treatment abroad

      Medical Dialogues Bureau16 Dec 2019 9:00 AM IST
      New Delhi: The gleaming booth towered over the medical conference in Italy in October, advertising a new brand of antidote for opioid overdoses. "Be...
      GSK seeks marketing licence for baby-friendly HIV pill Dolutegravir

      GSK seeks marketing licence for baby-friendly HIV pill Dolutegravir

      Medical Dialogues Bureau15 Dec 2019 9:40 AM IST
      GSK's ViiV is planning licensing agreements with two generic drugmakers, Mylan Laboratories and Macleods Pharmaceuticals, who aim to make cheaper...
      Alkermes gets USFDA warning letter for misleading Vivitrol ads

      Alkermes gets USFDA warning letter for misleading Vivitrol ads

      Medical Dialogues Bureau15 Dec 2019 9:15 AM IST
      Users of Vivitrol as a treatment for opioid dependence should be made aware of the vulnerability to a potentially fatal overdose at the end of a...
      Regular review of CDSCO functioning, deaths due to spurious drugs: Minister

      Regular review of CDSCO functioning, deaths due to spurious drugs: Minister

      Medical Dialogues Bureau15 Dec 2019 9:15 AM IST
      New Delhi: Through a recent reply, the Union Health Minister, Dr Harsh Vardhan informed the Parliament about the regular review of the function of the...
      Sanofi lauded as newest member of Systems-based Pharmaceutics Alliance

      Sanofi lauded as newest member of Systems-based Pharmaceutics Alliance

      Medical Dialogues Bureau15 Dec 2019 8:59 AM IST
      The Alliance further comprises leading pharma companies Eli Lilly, GlaxoSmithKline, Pfizer and F. Hoffmann-La Roche and supplier of mechanistic...
      Biogen halts development of Gosuranemab, therapy for rare brain disease

      Biogen halts development of Gosuranemab, therapy for rare brain disease

      Medical Dialogues Bureau15 Dec 2019 8:58 AM IST
      The therapy, Gosuranemab, failed to hit statistical significance in its main goal and did not demonstrate effectiveness on key secondary goals when...
      Patent Infringement: Bristol-Myers wins case against Gilead; awarded USD 752 million in damages

      Patent Infringement: Bristol-Myers wins case against Gilead; awarded USD 752 million in damages

      Medical Dialogues Bureau14 Dec 2019 9:35 AM IST
      A jury in Los Angeles awarded the damages after finding that Yescarta, a treatment sold by Gilead's Kite Pharma unit, infringed on a patent...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok